1. Home
  2. IRDM vs PVLA Comparison

IRDM vs PVLA Comparison

Compare IRDM & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iridium Communications Inc

IRDM

Iridium Communications Inc

N/A

Current Price

$24.73

Market Cap

2.1B

ML Signal

N/A

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

N/A

Current Price

$140.54

Market Cap

1.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IRDM
PVLA
Founded
2000
2015
Country
United States
United States
Employees
N/A
14
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.9B
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
IRDM
PVLA
Price
$24.73
$140.54
Analyst Decision
Hold
Strong Buy
Analyst Count
6
17
Target Price
$27.33
$154.59
AVG Volume (30 Days)
2.1M
332.9K
Earning Date
05-15-2026
01-01-0001
Dividend Yield
2.50%
N/A
EPS Growth
12.77
N/A
EPS
1.06
N/A
Revenue
$871,659,000.00
N/A
Revenue This Year
$3.50
N/A
Revenue Next Year
$2.26
N/A
P/E Ratio
$22.60
N/A
Revenue Growth
4.93
N/A
52 Week Low
$15.65
$18.23
52 Week High
$33.34
$151.18

Technical Indicators

Market Signals
Indicator
IRDM
PVLA
Relative Strength Index (RSI) 62.64 71.46
Support Level $23.46 $76.95
Resistance Level $24.98 $151.18
Average True Range (ATR) 0.95 9.71
MACD -0.02 2.75
Stochastic Oscillator 93.15 84.79

Price Performance

Historical Comparison
IRDM
PVLA

About IRDM Iridium Communications Inc

Iridium Communications Inc is the commercial provider of communications services offering true globalised coverage, connecting people, organizations and assets to and from anywhere, in real time. The company is a provider of mobile voice and data communications services through a constellation of low earth-orbiting satellites. Iridium's solutions are ideally suited for industries such as maritime, aviation, government/military, emergency/humanitarian services, mining, forestry, oil and gas, heavy equipment, transportation, and utilities. Iridium also provides service to subscribers from the U.S. Department of Defense, as well as other civil and government agencies world-wide. The Company operates in one business segment, providing satellite communications services and products.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: